"it is for those with a very simplistic understanding of the subject."
Exactly this is HC not some CPA exam and regardless of the word used the 100+ million will have to be paid. As for my understand of EQR's financials. I have been 10 step in front of you's for years. Of course this is just to distract from the fact you don't want to acknowledge, they still have not fit a financial or production target and are still losing money and need 10's of millions for capex.
Are you with @gomer08 in believing "Next Qtrly report will prove you (me) wrong as EQR will most definetly be cash flow positive from both mines."
$100+m in Liabilities for what? 2 mines that makes no profit. A deposits costing them upkeep every year with no sign of production in site. At MC a 70% built plant that's 5 years over due for a profit and still needs a substantial amount of funds to complete. In 2022 it was claiming to be fully funded. Yet here in 2025 still not built and still raising money.
Do you not understand that because they ran out of water at MC, The plant was not running at the start of the year and then they ran out of explosive's. So they are yet to even expose the high grade ore.
Then at Saloro. They have not reported that February was a record production month. So that would mean the ramp up stalled back in November. 33000 MTU's for the Qty is no where near profitable.
So I changed the word. Care to get back to how they are going to make a profit.
O and the tungsten price is down again.
- Forums
- ASX - By Stock
- EQR
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
EQR
eq resources limited
Add to My Watchlist
10.8%
!
4.1¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-223
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.1¢ |
Change
0.004(10.8%) |
Mkt cap ! $111.8M |
Open | High | Low | Value | Volume |
4.0¢ | 4.2¢ | 3.7¢ | $306.8K | 7.833M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 78945 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 349999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 78945 | 0.038 |
2 | 104000 | 0.037 |
1 | 75000 | 0.035 |
3 | 165000 | 0.034 |
3 | 369581 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 349999 | 1 |
0.042 | 100000 | 1 |
0.043 | 88255 | 2 |
0.044 | 575714 | 3 |
0.045 | 1268034 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EQR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online